SHENZHEN, China, March 19 Winner Medical Group Inc.(NYSE Amex: WWIN; "Winner," or "the Company"), a manufacturer of medicaldressings, medical disposables and non-woven PurCotton(R) materials for themedical and consumer products industries, announced today that its commonstock has been approved for listing on the NASDAQ Global Market. The Companycurrently expects that its-common stock will commence trading on the NASDAQ onApril 6, 2010 and will continue to be listed under the ticker symbol "WWIN".
About Winner Medical:
Winner Medical is a leading manufacturer and the largest exporter byvolume in the medical dressing industry in China. Headquartered in Shenzhen,the Company has eight wholly-owned operating subsidiaries and four jointventures with over 5,000 employees. The Company engages in the manufacturing,sale, research, and development of medical care products, wound care products,home care products and PurCotton(R) products, a nonwoven fabric made from 100%natural cotton. The products are sold worldwide, with Europe, the UnitedStates, China and Japan serving as the top four markets. The Company currentlyholds more than sixty patents and patent applications for various products andmanufacturing processes and is one of the few Chinese companies licensed bythe U.S. Food and Drug Administration (FDA) to ship finished, sterilizedproducts directly to the United States market. To learn more about WinnerMedical, please visit Winner Medical's web site at:http://ir.winnermedical.com .
This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of1933, as amended, and Section 21E of the Securities Exchange Act of 1934, asamended. All statements, other than statements of historical fact includedherein are "forward-looking statements" including statements regarding WinnerMedical and its subsidiary companies' business strategy, plans and objectiveand statements of non-historical information. These forward-looking statementsare often identified by the use of forward-looking terminology such as"believes," "expects" or similar expressions, involve known and unknown risksand uncertainties. Although Winner Medical believes that the expectationsreflected in these forward-looking statements are reasonable, they do involveassumptions, risks and uncertainties, and these expectations may prove to beincorrect. You should not place undue reliance on these forward-lookingstatements, which speak only as of the date of this press release. WinnerMedical's actual results could differ materially from those anticipated inthese forward- looking statements as a result of a variety of factors,including those discussed in Winner Medical's periodic reports that are filedwith and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on itsbehalf are expressly qualified in their entirety by these factors. Other thanas required under the securities laws, Winner Medical does not assume a dutyto update these forward-looking statements.For more information, please contact: Company: Peng Zhai Investor Relations Manager Winner Medical Group Inc. Tel: +86-755-2806-6858 +86-755-2813-8888 x691 Email: email@example.com Web: http://ir.winnermedical.com Investors: Scott Powell HC International, Inc. Tel: +1-917-721-9480 Email: firstname.lastname@example.org Web: http://www.hcinternational.net
SOURCE Winner Medical Group Inc.